Intrusion INTZ 深 沪
等待开盘 12-16 09:30:00 美东时间
1.31
-0.150
-10.27%
华盛通- 最 高1.45
- 今 开1.45
- 成交量 11.52万股
- 最 低 1.31
- 昨 收 1.46
- 总市值 2606.26万
- 52周最高 7.34
- 市盈率 静 --
- 换手率 0.58%
- 52周最低 0.353
- 委 比 -75.63%
- 总股本 1989.51万
- 历史最高 598.00
- 量 比 2.07
- 振 幅 9.59%
- 历史最低 0.71
- 每 手 1
- 风险率 0.59%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅2566.67%！Ascendiant Capital上调GRI Bio目标价至36美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持GRI Bio"买入"评级，目标价从35美元升至36美元；Ascendiant Capital：维持Atossa Therapeutics"买入"评级，目标价从7.75美元升至8美元
12-09 10:32
CrowdStrike Stock Slides Despite Upbeat Q3, Falcon's Wingspan Widens
Shares of CrowdStrike tanked in early trading on Wednesday, despite the company reporting upbeat fiscal third-quarter results.
12-03 23:54
Shares of software companies are trading lower, possibly because of a rise in Treasury yields, which could pressure growth stocks. The sector may also be seeing weakness due to investor concerns about an AI bubble.
Shares of software companies are trading lower, possibly because of a rise in T...
12-02 03:07
Preview: Alarum Technologies's Earnings
Alarum Technologies (NASDAQ:ALAR) is gearing up to announce its quarterly earni...
11-25 22:01
12 Information Technology Stocks Moving In Wednesday's After-Market Session
Gainers Argo Blockchain (NASDAQ:ARBK) shares rose 3.3% to $0.24 during Wednesd...
11-20 05:07
电话会总结 ｜ Intrusion(INTZ)2025财年Q3业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Intrusion业绩会实录，以下是财务业绩回顾摘要： ## 1. 财务业绩 **营收表现：** - 第三季度总收入200万美元，环比增长5%，同比增长31% - 咨询收入150万美元，环比增长10万美元，同比增长40万美元 - Shield收入50万美元，环比持平，同比增长约10万美元 **盈利能力：** - 毛利率77%，同比下降58个基点 - 净亏损210万美元，每股亏损0.10美元，与去年同期持平 **运营费用：** - 运营费用360万美元，环比增长10万美元，同比增长40万美元 **现金状况：** - 截至9月30日现金及现金等价物2
11-12 12:12
Intrusion Q3 EPS $(0.10) Misses $(0.09) Estimate, Sales $1.966M Beat $1.907M Estimate
Intrusion (NASDAQ:INTZ) reported quarterly losses of $(0.10) per share which missed the analyst consensus estimate of $(0.09) by 11.11 percent. This is a 71.43 percent increase over losses of $(0.35) per share from the
11-12 05:07
A Glimpse of Silvaco Group's Earnings Potential
Silvaco Group (NASDAQ:SVCO) is preparing to release its quarterly earnings on W...
11-12 02:04
Earnings Scheduled For November 11, 2025
Companies Reporting Before The Bell • Gogoro (NASDAQ:GGR) is estimated to repor...
11-11 19:11
美股大行评级 | 潜在涨幅4347.41%！Ascendiant Capital上调PAVmed目标价至20美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持PAVmed"买入"评级，目标价从19美元升至20美元；Ascendiant Capital：维持Plus Therapeutics"买入"评级，目标价从20.5美元升至21美元
10-07 15:04
